Press release
Strategic Overview for Platelet-Rich Plasma Market Trends 2016 to 2024
Platelet rich plasma (PRP) is a blood plasma product in which concentration of platelets is elevated four to eight times than normal blood platelet concentration. PRP is also called platelet rich gel, platelet enriched plasma and platelet enriched gel. PRP is an effective treatment to treat various diseases such as orthopedic diseases, sports injuries, neurological diseases and cardiothoracic diseases. In addition, PRP therapy has an extensive application in cosmetic industry. This report studies the current scenario as well as future market potential for PRP globally.
The market overview section of the report comprises qualitative analysis of the overall PRP market considering the factors determining the market dynamics such as drivers, restraints and opportunities, along with Porter’s five force analysis and market attractiveness analysis. In addition, such as market opportunity analysis, and key industry developments has also been provided. Key industry developments include the major events occurred in past decade and are expected to occur during the forecast period and are likely to affect the market dynamics.
Global Platelet Rich Plasma (PRP) Market: Segmentation
The global PRP market has been segmented on the basis of types, origins and applications. On the basis of types, the global PRP market is categorized as pure-PRP (P-PRP), leukocyte-rich PRP (L-PRP) and pure-platelet-rich fibrin (P-PRF). Moreover, on the basis of origin, the PRP market has been segmented into autologous, homologous and allogeneic PRP.
Download Exclusive Global Strategic Business Report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4021
Furthermore, on the basis of applications, the global PRP market has been classified as neurosurgery, cosmetic surgery, orthopedic surgery, general surgery and others (cardiothoracic surgery, urology, periodontal surgery and oral and maxillofacial surgery). The market for these types, origins and applications has been extensively analyzed on the basis of factors such as usage pattern, sales revenue, geographic presence and technological developments. The market size and forecast in terms of revenue (USD million) for each of these segments have been provided for the period 2014 to 2024, considering 2015 as the base year. The report also provides the compounded annual growth rate (CAGR) for each segment for the forecast period 2016 to 2024.
Geographically, the PRP market has been classified into four segments namely, North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The market size and forecast for each region has been provided for the period 2014 to 2024, in terms of origin, types and applications, along with the CAGR (%) for the forecast period 2016 to 2024.
Global Platelet Rich Plasma (PRP) Market: Competitive Landscape
The report also provides a section on the competitive landscape, wherein the market share analysis of leading players in the global PRP market, in terms of percentage share in 2015 has been discussed. A list of recommendations has also been included for new entrants as well as existing market players to help them establish a strong presence in the market and increase their market share.
It concludes with the profiles of major players in the global PRP market such as AdiStem Ltd., Arthrex, Inc., Biomet, Inc., Cesca Therapeutics, Inc., DePuy Synthes, Inc., EmCyte Corporation, Exactech, Inc., Harvest Technologies Corp., Nuo Therapeutics, Inc., Regen Lab SA, and Stryker Corporation. The major market players are evaluated on various parameters such as company overview, financial overview, product portfolio, business strategies and recent developments.
Browse Full Research Report on Platelet Rich Plasma Market:
http://www.transparencymarketresearch.com/platelet-rich-plasma-market.html
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog:
https://tmrresearch.blogspot.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Strategic Overview for Platelet-Rich Plasma Market Trends 2016 to 2024 here
News-ID: 400355 • Views: …
More Releases from TMR - Research Reports
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during…
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the…
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016.
The global dental membrane and bone graft substitutes market is expected to…
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period.
By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment…
More Releases for PRP
Latest Study on Platelet Rich Plasma (PRP) Market Future Growth Predictions and …
The Global Platelet Rich Plasma (PRP) Market 2019-2026 increase in the number of orthopedic surgeries and sports injuries and rise in the number of cosmetic surgeries are driving the growth of the market. However, high cost of devices & therapy will limit the market growth.
The Global Platelet Rich Plasma (PRP) Market 2019 report includes Platelet Rich Plasma (PRP) Market Revenue, market Share, industry volume, and Trends, Growth aspects. Growing prevalence…
Platelet Rich Plasma (PRP) Market is expected to grow at a CAGR of roughly 13.3% …
New Study Report On "Platelet Rich Plasma (PRP) Market is expected to grow at a CAGR of roughly 13.3% | Analysis By PRP Type (P-PRP, L-PRP, L-PRF), By Players (DePuy Synthes, Stryker...), By Surgery (Orthopedic, Cosmetic, General...) & Region, Size & Forecast To 2023"
The worldwide market for Platelet Rich Plasma (PRP) is expected to grow at a CAGR of roughly 13.3% over the next five years, will reach 400 million…
Platelet Rich Plasma Market By PRP Type (Pure-PRP, Leucocyte Rich PRP, Pure Plat …
Platelet rich plasma (PRP) is a portion of the plasma fraction of analogous blood, which contains platelet concentration more than standard concentration. Platelets contains bio proteins that helps in healing, tissue regeneration, and blood loss. Platelet rich plasma protein consists of three proteins, which acts as cell adhesive molecules that are fibrin, fibronectin, and vitronectin. The use of platelet rich plasma therapy is tremendously increased after 2009 due to its…
Global Platelet Rich Plasma (PRP) Industry
Global Platelet Rich Plasma (PRP) Industry
Global PRP market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Harvest Technologies
DePuy Synthes
Stryker
Zimmer Biomet
Arthrex
Exactech
Emcyte Corporation
Arteriocyte
Adilyfe
Try Sample Report @ https://www.wiseguyreports.com/sample-request/1140003-global-prp-market-research-report-2017
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of PRP in…
Platelet Rich Plasma (PRP) Market Forecast 2017-2021
Platelet rich plasma (PRP) market has witnessed appreciable growth due to a growing number of devices being FDA approved in recent years; however the therapeutics market is anticipated to have an uncertain future, even as non-approved therapeutic applications flourish. Although various platelet rich plasma isolation devices have received 510(k) clearance, platelet rich plasma has not been approved for direct injection or implant without prior mixing with the bone graft materials.…
Competitive Landscape for PRP Market Key Trends 2024
Global Platelet Rich Plasma (PRP) Market: Snapshot
Of late, the global market for platelet rich plasma (PRP) has been witnessing a remarkable rise in its valuation. The upswing in the incidence of orthopedic diseases, propelled by the increasing cases of sports injuries, and the growing prevalence of cardiothoracic and neurological disorders has emerged as the main factor behind this tremendous growth of this market.
In addition to this, the surge in cosmetic…
